Rare diseases
Investigational molecules
Locations
Bulevard Siedinenie 49, 6304 Haskovo, Bulgaria
Medical Center Medtech Services Ltd. in Haskovo, Bulgaria specialises in clinical trials of conditions such as Systemic lupus erythematosus, Rheumatoid arthritis, Chronic spontaneous urticaria, Cardiovascular disorder, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
BulgariaRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
BulgariaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
BulgariaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
BulgariaA Phase 2 Study of LAD603 in Adults with Systemic Lupus Erythematosus and Active Skin Rash
BulgariaELV001 for Active Rheumatoid Arthritis in Patients with Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition
BulgariaStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
